Emergence and Targeting of Acquired and Hereditary Resistance to Multikinase RET Inhibition in Patients With RET-Altered Cancer

JCO Precis Oncol. 2019 Sep 11:3:PO.19.00189. doi: 10.1200/PO.19.00189. eCollection 2019.

Authors

Lori J Wirth¹, Takashi Kohno², Hibiki Udagawa³, Shingo Matsumoto³, Genichiro Ishii³, Kevin Ebata⁴, Brian B Tuch⁴, Edward Y Zhu⁴, Michele Nguyen⁴, Steve Smith⁴, Lauren M Hanson⁵, Michael R Burkard⁵, LouAnn Cable⁴, James F Blake⁴, Kevin R Condroski³, Barbara J Brandhuber³, Steve Andrews³, S Michael Rothenberg⁴, Koichi Goto³

Affiliations

¹ Massachusetts General Hospital Cancer Center, Boston, MA.
² National Cancer Research Institute, Tokyo, Japan.
³ National Cancer Center Hospital East, Kashiwa, Japan.
⁴ Loxo Oncology, Stamford, CT.
⁵ Array BioPharma, Boulder, CO.

No abstract available

Publication types

Case Reports